In the last twenty years we have observed a substantial improvement in the prognosis of breast cancer patients. The more effective therapies as well as the implementation in screening programs represent the basis of this phenomenon. Moreover, the new scientific acquisitions on tumor biology have opened the way to a more individualized treatment.
The multidisciplinary approach remains a cornerstone in the management of breast cancer, and the clinical decision making process should be the result of a direct interaction among breast pathologists, surgeons, medical oncologists, radiologists and radiotherapists.
This course is aimed to review the most updated scientific results for prevention, diagnosis and treatment of breast cancer. Clinical cases will be debated within working groups, and experts will be called to give their opinion and to discuss with the audience possible controversial issues in a fully interactive debate.

Pier Franco Conte
Dipartimento Integrato di Oncologia e Ematologia
Università degli Studi di Modena e Reggio Emilia
Policlinico di Modena

Gabriel N. Hortobagyi
Department of Breast Medical Oncology
University of Texas MD Anderson Cancer Center
Houston

Oncologists, radiologists, breast surgeons.

Application for ECM credits for Italian participants will be presented to the Italian Ministry of Health. The number of credits will be published on the Accademia Nazionale di Medicina's web site (visit). The credit certification is subject to:

• the accreditation by the Ministry of Health
• the full attendance of the meeting
• the completion of the meeting evaluation test and the event evaluation form
• the correspondance between the participant's profession and the professional categories the course is aimed to (physicians specialized in Oncology, Radiology, Breast Surgery).